Series A - NeRRe Therapeutics
Investment Firm
Overview
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Announced Date
Dec 19, 2012
Funding Type
Series A
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
Round Details and Background
NeRRe Therapeutics raised $18400000 on 2012-12-19 in Series A
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 07, 2021 |  Series B - NeRRe Therapeutics | 6 | - | 27.6M |
| Jan 05, 2017 | Series B - NeRRe Therapeutics | 5 | - | 28.6M |
| Dec 19, 2012 | Series A - NeRRe Therapeutics | 3 | - | 18.4M |
Recent Activity
There is no recent news or activity for this profile.